Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study

Psychopharmacology
J RibaM J Barbanoj

Abstract

The "fear-potentiated startle" paradigm has been extensively used in animal studies, and more recently in human experimental psychopharmacology to evaluate the effects of anxiogenic and anxiety-relieving drugs. Previous human studies have shown that both the baseline and the fear-potentiated responses can be inhibited by anxiety-relieving drugs, suggesting drug activity on two different emotional states, the former reflecting a resting condition and the latter more akin to pathological anxiety. To examine to which extent the reductions induced by a benzodiazepine on the basic and the fear-potentiated startle responses are of equal intensity, and whether or not the drug shows a predominant, i.e., selective, effect on either. The effects of three increasing doses of the benzodiazepine alprazolam (0.25, 0.5, and 1.0 mg) were assessed on the human baseline and fear-potentiated startle responses. Twelve healthy volunteers attended the laboratory on four experimental days and received either alprazolam or placebo according to a double-blind crossover balanced design. Startle recordings were undertaken 2 h after drug intake. Fear potentiation was implemented by means of an electric-shock-anticipation experimental procedure. Additional...Continue Reading

Associated Clinical Trials

Citations

Oct 4, 2006·Psychopharmacology·Estibaliz ArceMartin P Paulus
Dec 7, 2007·Psychopharmacology·Christian Grillon
Oct 6, 2010·Psychopharmacology·Kiersten S SmithUwe Rudolph
Jun 13, 2003·Drug Discovery Today·Paul J Whiting
Sep 2, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Christian Grillon, Johanna Baas
Oct 28, 2004·Behavioral Neuroscience·Christian GrillonJean Milstein
Aug 21, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael DavisChristian Grillon
Apr 8, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Leigh MilesDavid Walker
Feb 16, 2005·Annual Review of Psychology·Michael Domjan
Jan 12, 2005·Journal of Clinical Psychopharmacology·Richard C Oude VoshaarFrans G Zitman
Dec 5, 2015·Frontiers in Psychology·Bradly T StoneChris Berka
Aug 19, 2007·Biological Psychology·Shmuel LissekChristian Grillon
Jul 12, 2012·Human Psychopharmacology·Dean T AchesonVictoria B Risbrough
Sep 20, 2005·Brain Research. Cognitive Brain Research·Jordi RibaManel J Barbanoj
Sep 15, 2005·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Miquel-Angel FullanaRafael Torrubia
Mar 12, 2013·Neuroscience·M RazafshaF H Kobeissy
Sep 27, 2014·Neurobiology of Learning and Memory·Pau Alexander PackardLluís Fuentemilla
May 23, 2008·Journal of Affective Disorders·Laurie O'Brien-SimpsonNicholas B Allen
Mar 28, 2008·The International Journal of Neuropsychopharmacology·Shlomit Jacobson-PickGal Richter-Levin
Apr 29, 2016·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Pritha Roy, Sujita Kumar Kar
Apr 18, 2003·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·F G GraeffF S Guimarães
Mar 31, 2009·Journal of Psychopharmacology·F KlumpersJ M P Baas
May 13, 2005·Journal of Psychopharmacology·S J GrahamJ A Wagner
Jul 3, 2003·Nature Reviews. Drug Discovery·Richard Frank, Richard Hargreaves
Jul 19, 2011·Physiological Measurement·Francesc ClariáPere Caminal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.